These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 21516018)
21. Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol. Filippi L; Tamburini A; Berti E; Perrone A; Defilippi C; Favre C; Calvani M; Della Bona ML; la Marca G; Donzelli G Pediatr Blood Cancer; 2016 Jul; 63(7):1290-2. PubMed ID: 27100060 [TBL] [Abstract][Full Text] [Related]
22. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants. Wang Y; Kong L; Sun B; Cui J; Shen W J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003 [TBL] [Abstract][Full Text] [Related]
23. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon. Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627 [No Abstract] [Full Text] [Related]
25. Kaposiform hemangioendothelioma: a rare cause of spontaneous hemothorax in infancy. Review of the literature. San Miguel FL; Spurbeck W; Budding C; Horton J J Pediatr Surg; 2008 Jan; 43(1):e37-41. PubMed ID: 18206444 [TBL] [Abstract][Full Text] [Related]
26. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262 [TBL] [Abstract][Full Text] [Related]
27. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D. Hu B; Lachman R; Phillips J; Peng SK; Sieger L J Pediatr Hematol Oncol; 1998; 20(6):567-9. PubMed ID: 9856681 [TBL] [Abstract][Full Text] [Related]
28. Successful treatment of retroperitoneal infantile hemangioendothelioma with Kasabach-Merritt syndrome using steroid, alpha-interferon, and vincristine. Yoon HS; Lee JH; Moon HN; Seo JJ; Im HJ; Goo HW J Pediatr Hematol Oncol; 2009 Dec; 31(12):952-4. PubMed ID: 19875968 [TBL] [Abstract][Full Text] [Related]
29. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511 [TBL] [Abstract][Full Text] [Related]
35. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Hauer J; Graubner U; Konstantopoulos N; Schmidt S; Pfluger T; Schmid I Pediatr Blood Cancer; 2007 Nov; 49(6):852-4. PubMed ID: 16411198 [TBL] [Abstract][Full Text] [Related]
36. Kaposiform hemangioendothelioma. An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy. Vin-Christian K; McCalmont TH; Frieden IJ Arch Dermatol; 1997 Dec; 133(12):1573-8. PubMed ID: 9420544 [TBL] [Abstract][Full Text] [Related]
37. Multifocal kaposiform hemangioendothelioma in multiple visceral organs: an autopsy of 9-day-old female baby. Nakaya T; Morita K; Kurata A; Ushiku T; Igarashi T; Kuroda M; Fukayama M Hum Pathol; 2014 Aug; 45(8):1773-7. PubMed ID: 24931465 [TBL] [Abstract][Full Text] [Related]
38. Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma. Drucker AM; Pope E; Mahant S; Weinstein M J Cutan Med Surg; 2009; 13(3):155-9. PubMed ID: 19426625 [TBL] [Abstract][Full Text] [Related]
39. Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis. Blei F Pediatr Blood Cancer; 2015 Apr; 62(4):551-2. PubMed ID: 25559734 [No Abstract] [Full Text] [Related]